Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,127.20
(
0.47%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
99.21
(
-1.44%
)
Bitcoin
74,039.34
(
0.13%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

zipjet

Send PM Follow Ignore
Followers 36
Posts 2637
Boards Moderated 0
Alias Born 10/06/2003

zipjet

Re: jbog post# 99802

Tuesday, 07/27/2010 7:25:09 AM

Tuesday, July 27, 2010 7:25:09 AM

Post# of 257253

The Court held a status conference on July 26, 2010 and set a schedule for consideration of preliminary injunctive relief, with a hearing to be held on August 17, 2010. At the status conference, the Court did not place any restrictions on the sale of enoxaparin sodium injection by Sandoz.



In other words, NO TRO ISSUED.

Technically, it is not clear whether the TRO was denied or just passed to the PL hearing. But it really makes no difference. In effect, the TRO was denied.

ij

There are times when rules and precedents cannot be broken; others when they cannot be adhered to with safety. (Thomas Joplin)

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now